Diana D. Kang

Diana D. Kang's research focuses on designing lipid nanoparticles (LNPs) — tiny fat-based particles — to deliver mRNA and other RNA-based therapies to specific tissues, especially the brain and central nervous system, but also lungs, tumors, and wounds. This work spans applications like crossing the blood-brain barrier for neurological disease treatment, cancer immunotherapy, antiviral therapies, and wound healing. Prospective students would work on chemistry and materials engineering problems related to drug delivery, combined with molecular biology techniques for testing these therapies in cells and animals.

Publication output has grown substantially over the last decade, rising from no publications before 2020 to a peak of 13 in 2025, indicating an accelerating and increasingly active research output.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026